Ali Hasanzadeh

Prof. Ali Hasanzadeh

Golestan University of Medical Sciences
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
AZArghavan Zebardast
Arghavan Zebardast
PHParastoo Hosseini
Parastoo Hosseini
AHAli Hasanzadeh
Ali Hasanzadeh
TLTayebeh Latifi
Tayebeh Latifi

14 December 2022 in Journal of Medical Microbiology
Verified
Journal Article
Open access
AZArghavan Zebardast
Arghavan Zebardast
TLTayebeh Latifi
Tayebeh Latifi
MSMehdi Shabani
Mehdi Shabani
AHAli Hasanzadeh
Ali Hasanzadeh
MDManizheh Danesh
Manizheh Danesh
FSFarzin Sadeghi
Farzin Sadeghi
Introduction. Coronavirus disease 2019 (COVID-19) identified in December 2019 in Wuhan, China, is associated with high mortality rates worldwide. Hypothesis/Gap Statement. Thrombotic problems, such as coagulopathy, are common in COVID-19 patients. Despite anticoagulation, thrombosis is more common in patients in the intensive care unit and patients with more severe disease. Although the exact mechanisms of coagulopathy in COVID-19 patients are still unclear, studies showed that overactivation of the renin-angiotensin system (RAS), cytokine storm, endothelial damage, formation of neutrophil extracellular traps (NETs), and also extracellular vesicles (EVs) in response to COVID-19 induced inflammation can lead to systemic coagulation and thrombosis. Aim. The management of COVID-19 patients requires the use of basic and readily available laboratory markers, both on admission and during hospitalization. Because it is critical to understand the pathophysiology of COVID-19 induced coagulopathy and treatment strategies, in this review we attempt to explain the underlying mechanism of COVID-19 coagulopathy, its diagnosis, and the associated successful treatment strategies. Conclusion. The exact mechanisms behind COVID-19-related coagulopathy are still unclear, but several studies revealed some mechanisms. More research is needed to determine the best anticoagulant regimen and to study other therapeutic options.

26 May 2021 in Future Virology
Verified
Journal Article
Closed access
SGSomayeh Oladi Ghadicolaee
Somayeh Oladi Ghadicolaee
MPMaryam Pazhoohan
Maryam Pazhoohan
AHAli Hasanzadeh
Ali Hasanzadeh
MNMahvash Nematolahi
Mahvash Nematolahi
YYYousef Yahyapour
Yousef Yahyapour
FSFarzin Sadeghi
Farzin Sadeghi
Background: HPV-16 has a significant role in cervical cancers; co-infection with human cytomegalovirus (HCMV) as an oncomodulatory pathogen may increase the risk of carcinogenesis. This study aimed...

1 August 2023 in Future Virology
Verified
Journal Article
Closed access
ZVZeinab Vosough
Zeinab Vosough
FSFarzin Sadeghi
Farzin Sadeghi
GKGhodsieh Kamrani
Ghodsieh Kamrani
AHAli Hasanzadeh
Ali Hasanzadeh
MRMohammad Ranaee
Mohammad Ranaee
Aim: We aimed to investigate the presence of human papillomavirus type 197 (HPV197) in patients with cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Materials & methods: 58 ... Plain language summary The skin is one of the most common sites of cancer. Several risk factors have been studied for skin cancer, including viral infections. The human papillomavirus (HPV) is one ...